Rising Creatinine on Your Report — What It Means

A rising creatinine result during immunotherapy usually means the kidneys are inflamed — most often immune-related nephritis, where an overactive immune response affects the kidneys' filtering tissue rather than the cancer itself. NCCN and ASCO management guidance for checkpoint inhibitor immunotherapy lists this among the immune-related adverse events (irAEs) that routine blood tests are designed to pick up.

Creatinine doesn't appear on your report as an isolated number either — your oncology team compares it to your own baseline creatinine (your usual level from before or early in treatment), then looks at how many times above that baseline you are. That multiple, not the raw number alone, is what guides the next step, which is why the table below matters more than the number by itself.

This page explains what the report is telling you and when to act on it — not how to manage kidney inflammation yourself. See "What happens next" below for how it's actually treated.

For most patients, no — dialysis is only needed in the small proportion of cases where kidney inflammation reaches a severe grade, and even then it is usually temporary, while the kidneys recover. Grade 1 and Grade 2 rises are typically managed with monitoring, a paused dose, and steroid medication alone; dialysis is reserved for the more severe end of the scale described in the table above.

Because a severe reaction can also involve other organs affected by the same immune overactivation, watch for these signs alongside a known creatinine rise — call now for any of these, don't wait to see if they pass:

Your oncology team will typically repeat the kidney function tests and review your other medicines and hydration status to confirm the cause, then grade the result and decide whether immunotherapy continues, pauses, or stops for now. This review also helps rule out dehydration, a recent contrast-dye scan, or an unrelated medicine, so the reaction is treated for what it actually is rather than assumed.

For Grade 1 rises, monitoring alone with more frequent blood tests is common. For Grade 2 and above, immunotherapy is usually paused and a steroid course — dosed and tapered by your treating oncologist — is often started to calm the immune reaction; higher grades are usually managed jointly with a nephrologist. If you want to understand what a steroid course for an irAE actually involves and why carrying a card about it matters, our guide on carrying a steroid emergency card covers the practical side.

Whether and when immunotherapy restarts afterwards is decided case by case by your oncologist and tumour board, based on how your kidney function recovers — never assumed either way in advance.

Not always. A rise in creatinine can also come from dehydration, a recent CT scan using contrast dye, an unrelated medicine, or a pre-existing kidney condition — which is exactly why a review of your hydration, medicines and recent scans is part of the same-day work-up, not an afterthought. Immune-related nephritis is diagnosed by ruling these other causes out, alongside the pattern and timing of the rise relative to your immunotherapy doses. Our detailed guide on kidney inflammation (nephritis) from immunotherapy covers how it's actually diagnosed and treated.

Kidney reactions are one part of a wider group of reactions that can affect the heart, kidneys, muscles and nerves together. If you're also noticing muscle weakness, our page on Muscle Weakness and Myositis on Immunotherapy explains how that's told apart, and Numbness, Tingling and Nerve Problems on Immunotherapy covers nerve-related symptoms. If a routine blood count looked unusual alongside your creatinine, see Immune Effects on the Blood: Low Counts and Clotting Problems.

For the full picture of when any immunotherapy side effect needs same-day care, see our immunotherapy emergencies: symptoms that need care today guide. If muscle weakness or nerve symptoms are your main concern right now, see Muscle Weakness and Myositis on Immunotherapy or Numbness, Tingling and Nerve Problems on Immunotherapy. For the wider picture of how immunotherapy is delivered and monitored at CION, see the immunotherapy overview.